Right-sized multi-product manufacturing for biologics | AIChE

Right-sized multi-product manufacturing for biologics

The COVID pandemic has emphasized the need for local, agile pharmaceutical manufacturing, particularly for biologics and vaccines. This webinar presents a disruptive approach to biologics manufacturing based on small-scale, modular manufacturing technologies, which could enable the regional production of protein-based therapeutics, vaccines, and reagents.

Presenter


Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. All other uses are forbidden without the express consent of the author(s). For permission to re-use, please contact chemepermissions@aiche.org.

  • AIChE Pro Members - Free
  • AIChE Graduate Student Members - Free
  • AIChE Undergraduate Student Members - Free
  • AIChE Explorer Members - $109.00
  • Non-Members - $109.00
Do you already own this? Log In for instructions on accessing this content.
  • Source:
    PD2M - Pharmaceutical Discovery, Development and Manufacturing Forum
  • Language:
    English
  • Skill Level:
    Intermediate
  • Duration:
  • PDHs:
    0.00